Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Dutasteride 0.5mg was found to be more effective than finasteride 1mg in treating male pattern hair loss, with similar side effects.

Dutasteride is more effective than finasteride for hair loss but may affect male fertility and should be used cautiously.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.

New methods for measuring dutasteride are effective and reliable.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

Artocarpus heterophyllus seed extract may help treat prostate inflammation without side effects.

Dutasteride more effectively treats hair loss than finasteride, but may increase risk of altered libido.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

These medications for BPH have known risks and may have new side effects.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Combination therapy is more effective for prostate volumes over 60 ml.

Finasteride may reduce prostate cancer risk.

5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Androgen lowering medications don't significantly change HCV-related liver cancer risk in men.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Dutasteride and finasteride don't raise erectile dysfunction risk.

Finasteride effectively reduces DHT and E2 levels, helping with prostate enlargement.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Dutasteride did not change rat spermatogenesis or oxidative stress but needs more research.

Dutasteride reduces DHT more than finasteride, but both drugs improve BPH symptoms similarly.

Steroid 12 shows promise as a targeted treatment for prostate cancer by selectively reducing cell growth and increasing cell death.

MK-386 lowers DHT in blood and skin but not in semen.